Ripac New Build | Latest news
Ripac New Build | Media Gallery
Ground-breaking Ceremony
Friday, February 28, 2025
Ripac New Build | News Channels
Ripac New Build Newsletter
Follow the journey of the Ripac New Build project.Follow on LinkedIn
More information
About Ripac-Labor
Ripac-Labor GmbH, a fully owned subsidiary of Dopharma International B.V., specializes in veterinary services and the production of autogenous vaccines for livestock. These customized vaccines provide targeted protection against farm-specific pathogens, offering a crucial tool for disease prevention and control. The expansion of Ripac-Labor’s production capabilities further strengthens the Dopharma group’s position in the European veterinary market.
The company currently employs 48 academic specialists, experienced laboratory technicians, and other well-trained staff.
About the Dopharma Group
Dopharma is a family-owned pharmaceutical company dedicated to producing and supplying high-quality veterinary pharmaceuticals for livestock since 1969. With 95% of its veterinary pharmaceuticals manufactured in-house at its GMP-certified production facilities, Dopharma ensures strict quality control and continuous innovation. The company’s mission is to provide smart, science-driven solutions that support the health and productivity of livestock worldwide.
Media inquiries
For media inquiries which are not available on this site, please contact [email protected].